119 related articles for article (PubMed ID: 3904325)
41. Role of retraction pockets in cholesteatoma formation.
Wells MD; Michaels L
Clin Otolaryngol Allied Sci; 1983 Feb; 8(1):39-45. PubMed ID: 6831754
[TBL] [Abstract][Full Text] [Related]
42. Clinical aspects of cholesteatoma in the adult middle ear and mastoid.
Dawes JD
Acta Otorhinolaryngol Belg; 1980; 34(1):107-13. PubMed ID: 7468190
[No Abstract] [Full Text] [Related]
43. Experimental retraction pocket cholesteatoma.
Wolfman DE; Chole RA
Ann Otol Rhinol Laryngol; 1986; 95(6 Pt 1):639-44. PubMed ID: 3789599
[TBL] [Abstract][Full Text] [Related]
44. Retraction pockets and attic cholesteatomas.
Sadé J
Acta Otorhinolaryngol Belg; 1980; 34(1):62-84. PubMed ID: 6162358
[TBL] [Abstract][Full Text] [Related]
45. Temporal bone histopathology in chronically infected ears with intact and perforated tympanic membranes.
da Costa SS; Paparella MM; Schachern PA; Yoon TH; Kimberley BP
Laryngoscope; 1992 Nov; 102(11):1229-36. PubMed ID: 1405982
[TBL] [Abstract][Full Text] [Related]
46. [Adhesive process and cholesteatoma in the sequel of tubal disfunction (author's transl)].
Zechner G
Laryngol Rhinol Otol (Stuttg); 1980 Mar; 59(3):179-84. PubMed ID: 7442402
[TBL] [Abstract][Full Text] [Related]
47. Cholesteatoma. Experimental induction in the Mongolian Gerbil, Meriones Unguiculaus.
McGinn MD; Chole RA; Henry KR
Acta Otolaryngol; 1982; 93(1-2):61-7. PubMed ID: 7064697
[TBL] [Abstract][Full Text] [Related]
48. Images in clinical medicine. Cholesteatoma.
Todd NW
N Engl J Med; 1994 Nov; 331(20):1347. PubMed ID: 7935704
[No Abstract] [Full Text] [Related]
49. Effect of 5-fluorouracil in cholesteatoma development in an animal model.
Wright CG; Bird LL; Meyerhoff WL
Am J Otolaryngol; 1991; 12(3):133-8. PubMed ID: 1928597
[TBL] [Abstract][Full Text] [Related]
50. Gerbilline cholesteatoma development Part III. Increased proliferation index of basal keratinocytes of the tympanic membrane and external ear canal.
Tinling SP; Chole RA
Otolaryngol Head Neck Surg; 2006 Jul; 135(1):116-23. PubMed ID: 16815195
[TBL] [Abstract][Full Text] [Related]
51. [Monostotic fibrous dysplasia of the temporal bone coinciding with cholesteatoma].
Ramírez Camacho RA; López Cortijo C; Mata N
Acta Otorrinolaringol Esp; 1993; 44(6):455-6. PubMed ID: 8155362
[TBL] [Abstract][Full Text] [Related]
52. [Experimentally produced cholesteatoma (author's transl)].
Steinbach E
Laryngol Rhinol Otol (Stuttg); 1978 Aug; 57(8):724-33. PubMed ID: 682791
[TBL] [Abstract][Full Text] [Related]
53. Sialomucin in middle ear cholesteatoma perimatrix.
Nagai T; Kawano J; Suganuma T
Acta Otolaryngol; 1992; 112(4):686-90. PubMed ID: 1279931
[TBL] [Abstract][Full Text] [Related]
54. [Cholesteatoma of the ear destroying the pyramid of the temporal bone and spreading to the base of the skull].
Vaĭshenker PG; Nezhdanova SM
Vestn Otorinolaringol; 1979; (4):70-1. PubMed ID: 483525
[No Abstract] [Full Text] [Related]
55. Cholesterol in cholesteatoma and in the otitis media syndrome.
Sadé J; Teitz A
Am J Otol; 1982 Jan; 3(3):203-8. PubMed ID: 7198868
[TBL] [Abstract][Full Text] [Related]
56. Histomorphological data on human auditory tube dysfunction.
Zechner G
J Laryngol Otol; 1981 Mar; 95(3):229-37. PubMed ID: 7462789
[No Abstract] [Full Text] [Related]
57. Middle ear epithelium in chronic ear disease.
Karma P; Palva T
Acta Otolaryngol; 1973 Apr; 75(4):271-2. PubMed ID: 4702614
[No Abstract] [Full Text] [Related]
58. [Pre-cholesteatoma status].
Lacher G
Rev Laryngol Otol Rhinol (Bord); 1988; 109(3):223-9. PubMed ID: 3187210
[No Abstract] [Full Text] [Related]
59. [Expression of 4F2-activation antigen in middle ear cholesteatoma].
Holly A; Bujía J; Sanchez-Madrid F
Laryngorhinootologie; 1993 Jul; 72(7):324-7. PubMed ID: 8369083
[TBL] [Abstract][Full Text] [Related]
60. The postero-superior quadrant.
Dawes JD
J Laryngol Otol; 1974 Oct; 88(10):955-67. PubMed ID: 4470583
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
